SUN — Surgical Innovations Cashflow Statement
0.000.00%
Last trade - 00:00- £4.20m
- £4.05m
- £11.60m
Annual cashflow statement for Surgical Innovations, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.456 | 0.264 | -0.509 | -1.94 | -0.895 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.02 | -0.27 | -0.031 | 1.13 | 0.014 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.844 | -0.095 | 0.183 | 0.043 | 0.792 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.433 | 0.486 | 0.4 | -0.074 | 0.569 |
| Capital Expenditures | -0.657 | -1.08 | -0.688 | -0.335 | -0.227 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.657 | -1.08 | -0.688 | -0.335 | -0.227 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.532 | -0.935 | -0.672 | -0.626 | 0.271 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.63 | -1.45 | -0.987 | -1.02 | 0.616 |